TXN · Texas Instruments Inc

Security converts to common stock on a one-for-one basis.

Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

Security converts to common stock on a one-for-one basis.

Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 25, 2019.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $307.29 to $308.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $308.30 to $309.16. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $308.85 to $309.53. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 27, 2023.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.32 to $309.80. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $306.94 to $307.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $305.91 to $306.89. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 25, 2019.

The option became exercisable in four equal annual installments beginning on January 25, 2020.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $295.11 to $295.33. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $279.87 to $280.755. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 26, 2018.

The option became exercisable in four equal annual installments beginning on January 24, 2021.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $278.5 to $279.0345. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $280.04 to $280.93. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 25, 2020.

The option became exercisable in four equal annual installments beginning on January 25, 2019.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $279.15 to $280.0367. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option will become exercisable in four equal annual installments beginning on January 24, 2021.

The option became exercisable in four equal annual installments beginning on January 24, 2021.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $278.99 to $279.92. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $270.04 to $271.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 28, 2022.

The option became exercisable in four equal annual installments beginning on January 24, 2021.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $269.04 to $270.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

The option became exercisable in four equal annual installments beginning on January 27, 2023.

The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $271.05 to $271.79. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.